Systematic Review and Comparative Meta-Analysis of Outcomes Following Pedicled Muscle versus Fasciocutaneous Flap Coverage for Complex Periprosthetic Wounds in Patients with Total Knee Arthroplasty

Article information

Arch Plast Surg. 2017;44(2):124-135
Publication date (electronic) : 2017 March 15
doi : https://doi.org/10.5999/aps.2017.44.2.124
1Department of Plastic Surgery, Georgetown University Hospital, Washington, DC, USA.
2Department of Orthopaedic Surgery, Georgetown University Hospital, Washington, DC, USA.
Correspondence: Karen Kim Evans. Department of Plastic Surgery, Center for Wound Healing, Georgetown University Hospital, 3800 Reservoir Road, 1-PHC, Washington, DC 20007, USA. Tel: +1-202-444-6161, Fax: +1-866-990-5515, karen.k.evans@gunet.georgetown.edu
Received 2016 August 12; Revised 2017 January 10; Accepted 2017 January 12.

Abstract

Background

In cases of total knee arthroplasty (TKA) threatened by potential hardware exposure, flap-based reconstruction is indicated to provide durable coverage. Historically, muscle flaps were favored as they provide vascular tissue to an infected wound bed. However, data comparing the performance of muscle versus fasciocutaneous flaps are limited and reflect a lack of consensus regarding the optimal management of these wounds. The aim of this study was to compare the outcomes of muscle versus fasciocutaneous flaps following the salvage of compromised TKA.

Methods

A systematic search and meta-analysis were performed to identify patients with TKA who underwent either pedicled muscle or fasciocutaneous flap coverage of periprosthetic knee defects. Studies evaluating implant/limb salvage rates, ambulatory function, complications, and donor-site morbidity were included in the comparative analysis.

Results

A total of 18 articles, corresponding to 172 flaps (119 muscle flaps and 53 fasciocutaneous flaps) were reviewed. Rates of implant salvage (88.8% vs. 90.1%, P=0.05) and limb salvage (89.8% vs. 100%, P=0.14) were comparable in each cohort. While overall complication rates were similar (47.3% vs. 44%, P=0.78), the rates of persistent infection (16.4% vs. 0%, P=0.14) and recurrent infection (9.1% vs. 4%, P=0.94) tended to be higher in the muscle flap cohort. Notably, functional outcomes and ambulation rates were sparingly reported.

Conclusions

Rates of limb and prosthetic salvage were comparable following muscle or fasciocutaneous flap coverage of compromised TKA. The functional morbidity associated with muscle flap harvest, however, may support the use of fasciocutaneous flaps for coverage of these defects, particularly in young patients and/or high-performance athletes.

INTRODUCTION

Wound complications after total knee arthroplasty (TKA) are multifactorial and result from a culmination of local, host-specific, and environmental influences. In general, systemic comorbidities (i.e., diabetes, collagen vascular disease, or obesity), chronic immunosuppression, smoking, and malnutrition retard wound healing and contribute to higher rates of incisional dehiscence [123]. Pre-existent scarring, fibrosis, and irradiation further compromise local perfusion, particularly in the setting of poor operative technique and/or excessive mechanical stress from premature mobilization [456]. Despite efforts to control modifiable risk factors, delayed wound healing affects up to 20% of knee joint replacements and increases the probability of periprosthetic infection, hardware exposure, and above-knee amputation [17]. Although infrequent, these outcomes have devastating implications with respect to the cost and duration of hospitalization, functional recovery, and quality of life for affected individuals [8].

Currently, there are no universal, evidence-based guidelines for the management of skin necrosis and/or complex soft tissue loss following TKA. Preventative measures (i.e., optimal incision placement, aseptic technique, tension-free closure, adequate early immobilization, etc.) offer the best opportunity for uncomplicated healing and rapid functional recovery [910]. If wound breakdown does occur, however, early plastic surgery consultation and prompt intervention optimize the chances for successful device and limb salvage. Systematic evaluation of patient comorbidities and wound-related factors including the extent and depth of involvement, presence of infection, and exposure of the implant and/or adjacent subfascial structures should guide the reconstructive plan as well as the need for hardware removal [311].

In the presence of actual or threatened hardware exposure, flap-based reconstruction is indicated to provide durable, well-vascularized coverage that can withstand the dynamic stresses of ambulation. The standard muscle flap for knee coverage historically has been the gastrocnemius muscle flap; however with the advent of local and free flap techniques, other fasciocutaneous flaps have become popular. Numerous options have been described, ranging from local fasciocutaneous or muscle flaps to pedicled or free perforator flaps, combined flaps, and composite tissue constructs [3111213141516171819]. Nevertheless, data directly comparing the functional performance, long-term salvage rate, morbidity, and quality-of-life outcomes among the various techniques are limited and reflect a general lack of consensus regarding the optimal management of these wounds. The purpose of this systematic review and meta-analysis was to critically evaluate the spectrum of reported outcomes and morbidities associated with muscle versus fasciocutaneous flap coverage of periprosthetic knee defects in patients with TKA.

METHODS

Literature search methodology

A literature search was performed using the MEDLINE, Ovid, and PubMed electronic databases with the following search terms and Boolean operators: knee arthroplasty [OR] knee prosthesis [AND] exposed hardware [OR] infection [OR] wound healing [AND] surgical flaps [OR] myocutaneous flap [OR] perforator flap [AND] ambulation [OR] limb salvage.

Selection criteria

The article review and selection process was limited to English-language publications between January 1950 and February 2016. Studies were included if they reported outcomes following muscle and/or fasciocutaneous flap coverage of wounds resulting from infection or healing complications after knee joint replacement. An attempt was made to evaluate quality-of-life indicators following flap-based reconstruction in this setting; however, these data were uncommon and inconsistently reported among studies. Descriptive, technical, cadaveric, and/or animal studies, as well as those that evaluated techniques other than flap-based reconstruction, were excluded. As more recalcitrant wounds were thought to require microsurgical free tissue transfer for soft tissue management, free flap reconstruction was also excluded from the review to limit confounding factors. The titles and abstracts were independently scrutinized by 2 authors (J.M.E. and M.V.D.) to identify relevant articles for full-text review. The review protocol is not available for remote access at time of publication.

Data extraction

The following data were extracted: study characteristics, including first author, publication year, and level of evidence; the number and type of flaps utilized; indications for flap reconstruction; functional outcomes; complications; and rates of limb as well as implant salvage. The analyzed flaps were classified by tissue composition (i.e., muscle/musculocutaneous or fasciocutaneous/perforator). Objective functional outcomes, including ambulatory status and range of motion, were primarily assessed through physical examination alone or in conjunction with instrument-assisted methods and/or validated outcome scales.

The validated outcome scales included the knee society scale (KSS), Western Ontario and McMaster universities osteoarthritis index (WOMAC), and the short form-12 (SF-12). The KSS is a 2-part assessment that evaluates knee joint integrity and function separately on individual 100-point scales. The knee assessment component consists of 3 parameters: pain, stability, and range of motion. The functional assessment consists of walking distance and stair climbing. The WOMAC is a 24-question survey that assesses the condition of patients with osteoarthritis. The survey is divided into 3 items (pain, stiffness, and functional limitation) with a total score of 96. The SF-12 is a 12-item, patient-reported survey of overall health that is divided into physical and mental health sections [20]. The scoring is based on standardized patient populations, with a mean score of 50 (standard deviation, 10) in the North American population.

Assessment of methodological quality

The methodological quality of nonrandomized comparative trials and case series was assessed using the Methodological Index for Non-Randomized Studies (MINORS) guidelines [21]. The MINORS guidelines consist of 12 indices, with each receiving a maximum of 2 points. Nonrandomized comparative trials can receive a maximum score of 24, while case series can receive a maximum score of 16. The MINORS guidelines are a validated instrument to assess the quality of nonrandomized comparative trials and case series in the surgical literature.

Statistical analysis and meta-analysis

To represent the power of each study included in this review and account for differences in the sample size among studies, weighted averages were calculated for means throughout this systematic review based on the number of patients in each study. Baseline comparisons between subgroups and the effect of flap type (muscle vs. fasciocutaneous) on rates of limb/implant salvage, complications, and functional outcomes were performed, when possible, utilizing the 2-tailed unpaired t-test and the chi-square test for data containing continuous and categorical variables, respectively. Confidence intervals (CIs) were set at 95% and calculated for descriptive variables such as limb salvage rates, complication rates, etc. P-values <0.05 were considered to indicate statistical significance. Limb salvage, device salvage, and complication rates were treated as dichotomous variables with their respective 95% CIs. Statistical heterogeneity was assessed using the modified Wald method for proportions [222324]. Cochran Q tests were performed and heterogeneity inferred from the calculated I2 values. Values of I2 >50% were considered to represent substantial heterogeneity. Forest plots are presented to summarize the data regarding primary outcomes (Figs. 1,2,3). Each horizontal line on the plot represents a case series included in the meta-analysis, with the length of the line corresponding to a 95% CI of the effect estimate. The effect estimate is noted with a solid black square, whose size represents the weight that the corresponding study exerted in the meta-analysis. The pooled estimate is noted as a diamond at the bottom of the plot. Publication bias is demonstrated with funnel plots for primary outcomes (Figs. 4,5,6). Effect estimates were presented according to study size and plotted against the rates of limb or device salvage. Statistical analyses were performed using SPSS Statistics (IBM Corp., Armonk, NY, USA) and plots generated with DistillerSR (Evidence Partners, Ottawa, Canada).

Fig. 1

Forest plot of limb salvage

Pooled rates of limb salvage across all studies (Cochran Q=40, df=17, P<0.0001; I2=57.5). df, degrees of freedom; LCL, lower confidence limits; UCL, upper confidence limits; WGHT, weight.

Fig. 2

Forest plot of device salvage

Pooled rates of device salvage across all studies (Cochran Q=18, df=13, P=0.16; I2=62.5). df, degrees of freedom; LCL, lower confidence limits; UCL, upper confidence limits; WGHT, weight.

Fig. 3

Forest plot of ambulation rates

Pooled rates of postoperative ambulation across all studies (Cochran Q=4, df=11, P=0.46; I2=1.75). df, degrees of freedom; LCL, lower confidence limits; UCL, upper confidence limits; WGHT, weight.

Fig. 4

Funnel plot of limb salvage

Funnel plot representation of publication bias in the reporting of rates of limb salvage. SD, standard deviation.

Fig. 5

Funnel plot of device salvage

Funnel plot representation of publication bias in the reporting of rates of device salvage. SD, standard deviation.

Fig. 6

Funnel plot of ambulation rates

Funnel plot representation of publication bias in the reporting of rates of postoperative ambulation. SD, standard deviation.

RESULTS

Study selection

The initial search as previously described yielded 825 citations. Of these citations, 113 articles were selected and reviewed in their entirety. Following the application of the exclusion criteria, 18 articles were ultimately deemed appropriate for analysis (Fig. 7) [162526272829303132333435363738394041]. Of these 18 articles, 16 were case series and 2 were case reports.

Fig. 7

Study attrition diagram

Diagram showing the study selection process and attrition.

Assessment of methodological quality

The overall quality of the included studies was considered to be satisfactory for the purposes of this review. Each study scored above 12 points on the MINORS score (Table 1).

Description of studies on flap coverage of total knee arthroplasty and assessment of study quality

Pooled study characteristics

A total of 172 flaps were performed in 172 patients to cover TKA defects, including 119 pedicled muscle flaps and 53 pedicled fasciocutaneous flaps. The muscle flap coverage of knee defects was limited to gastrocnemius flaps, used alone (n=109) or in combination with hemi-soleus flaps (n=10). The fasciocutaneous flaps were primarily perforator-based and included pedicled anterolateral thigh flaps (n=20), sural artery flaps (n=17), a superior lateral genicular artery flap (n=1), and random-pattern local flaps (n= 5). The most common indications for TKA were osteoarthritis (32.7% in the muscle flap cohort vs. 53.8% in the fasciocutaneous flap cohort, P=0.24) and the oncologic resection of periarticular tumors (10% in the muscle flap cohort vs. 41.2% in the fasciocutaneous flap cohort, P=0.18). Indications for flap coverage were variable and included periprosthetic infection (84.1% in the muscle flap cohort vs. 78.8% in the fasciocutaneous flap cohort, P=0.05) and wound healing complications (15.9% in the muscle flap cohort vs. 21.2% in the fasciocutaneous flap cohort, P=0.23). The pooled proportion of limb salvage for all studies was 74.4% (95% CI, 0.49–0.99), the pooled proportion of device salvage was 68.1% (95% CI, 0.42–0.94), and the overall complication rate was 48.9% (95% CI, 10–67). Table 2 demonstrates the outcomes of all studies included in this review. No significant differences were found in the in demographic data, the indications for joint replacement, or the timing/etiology of failed arthroplasty among patients who underwent muscle versus fasciocutaneous flap coverage of periprosthetic knee defects (Table 3).

Outcomes of the studies included in the review

Comparison of population characteristics between patient cohorts undergoing flap coverage of total knee arthroplasty defects

The protocols for revision TKA following hardware infection and/or exposure varied among the studies. Single-stage management of compromised hardware, with thorough debridement of the involved joint and immediate soft tissue coverage, was reported in 55.3% and 87% (P=0.6) of the patients in the muscle and fasciocutaneous flap cohorts, respectively. In contrast, antibiotic spacer exchange and simultaneous flap coverage, followed by delayed hardware replacement (i.e., 2-stage revision TKA), was reported in 44.7% and 13% of patients who received muscle and fasciocutaneous flaps, respectively (P=0.6).

Surgical outcomes and complications

The mean duration of follow-up for the patients in the muscle and fasciocutaneous cohorts was 6.4 years and 1.6 years, respectively (P=0.19) (Table 4). The overall rates of implant salvage (82.5% in the muscle flap cohort vs. 88.1% in the fasciocutaneous flap cohort, P=0.05) and amputation (10.2% in the muscle flap cohort vs. 0% in the fasciocutaneous flap cohort, P=0.14) were comparable among patients in both groups. Salvage arthrodesis was performed in 7.3% and 9.3% (P=0.12) of the patients with failed arthroplasty and/or non-salvageable joints in the muscle and fasciocutaneous flap cohorts, respectively. The overall complication rates (47.3% in the muscle flap cohort vs. 44% in the fasciocutaneous flap cohorts, P=0.78) as well as total flap loss (9.1% in the muscle flap cohort vs. 16% in the fasciocutaneous flap cohort, P=0.39), partial flap loss (1.8% in the muscle flap cohort vs. 1.6% in the fasciocutaneous flap cohort, P=0.45), and wound breakdown (12.7% in the muscle flap cohort vs. 8% in the fasciocutaneous flap cohort, P=0.2) were similar between cohorts. In contrast, both persistent infections (16.4% in the muscle flap cohort vs. 0% in the fasciocutaneous flap cohort, P=0.14) and recurrent infections (9.1% in the muscle flap cohort vs. 4% in the fasciocutaneous flap cohort, P=0.94) were more common following muscle flap coverage of periarticular defects, whereas higher rates of revision (7.3% in the muscle flap cohort vs. 12% in the fasciocutaneous flap cohort, P=0.53) and reoperation (32.7% in the muscle flap cohort vs. 44% in the fasciocutaneous flap cohort, P=0.86) were associated with fasciocutaneous flaps. None of these observations, however, were statistically significant.

Outcomes following muscle or fasciocutaneous flap coverage of compromised total knee arthroplasty

Functional outcomes

Notably, functional outcomes were sparsely reported, with only 3 studies (Table 5) utilizing validated outcomes scales, such as the KSS, WOMAC, and SF-12 [253139]. The mean postoperative knee motion among the 55 patients who underwent gastrocnemius flap coverage was 98.5° [2627282933343637]. These values, however, were not compared to preoperative baseline levels. Corten et al. [27] reported a 94% (53 vs. 103) increase between preoperative and postoperative KSS scores, among 24 patients who underwent gastrocnemius muscle flap coverage of knee defects. WOMAC scores were also reported by these authors, with an average increase of 19% over the preoperative baseline (43 vs. 51). The SF-12 scores reported by that study demonstrated a mean improvement of 4.3% (47.69 vs. 49.76) for the mental component and 14% (28.24 vs. 32.17) for the physical component. Another study of 21 patients who underwent gastrocnemius muscle coverage reported a mean postoperative KSS score of 77, in comparison to a preoperative value of 10.5 [34]. A single study reported functional outcomes for 15 patients who underwent sural artery perforator flap coverage using a validated scale. Their results indicate that patients had either good or excellent KSS scores following fasciocutaneous flap coverage; however, no quantitative numerical values were reported [31].

Studies reporting functional outcomes using validated scales following flap coverage of compromised total knee arthroplasty

Meta-analysis

Forest plots of the 3 meta-analyses are shown in Figs. 2,3,4. Both limb salvage (Cochran Q=40, degrees of freedom [df]=17, I2=57.5; P<0.0001) and device salvage (Cochran Q=18, df=13, I2=62.5; P=0.16) demonstrated substantial heterogeneity among studies, with the former reaching statistical significance. Ambulation rates showed less heterogeneity among studies (Cochran Q=4, df=11, I2=1.75; P=0.046). Publication bias is presented in Figs. 5 and 6, and a significant bias was found toward the publication of findings with successful outcomes.

DISCUSSION

Delayed healing, wound dehiscence, and infection with associated soft tissue loss are potentially catastrophic complications that affect upwards of 20% of knee joint replacements [7424344]. Breakdown of soft tissue over a prosthetic joint replacement leaves the prosthesis and surrounding bone susceptible to exposure, infection, and potential loss of both joint and limb. As roughly 30% of patients who present with superficial postoperative wound infections ultimately seed their hardware, early and aggressive management of infection and/or wound breakdown is imperative to ensure stable soft tissue coverage of the prosthesis and prevent further complications [35]. When primary closure is difficult or impossible, more expansive wounds generally require either local fasciocutaneous flaps or pedicled muscle flaps to obtain adequate coverage [11142845464748]. No consensus has been reached on the optimal coverage of these defects, and the results from our review of the current literature show no significant differences between the coverage options in terms of rates of device/limb salvage, complications, persistent joint infection, reoperation, arthrodesis, or amputation. These findings suggest that both muscle and fasciocutaneous flaps may offer comparable outcomes in the reconstruction of periprosthetic TKA wounds. We argue, therefore, that flap selection in these circumstances may break free from historical paradigms and take into account patient-centered factors such as functional morbidity and quality of life.

Historically, the gastrocnemius and soleus muscles have served as the workhorse flaps for the coverage of periarticular knee defects due to perceived benefits in the vascularity of muscle flaps [11]. Previous studies on animal models, however, have demonstrated equal or greater improvements in recipient-site perfusion with the application of fasciocutaneous flaps [4950]. In addition, the observed effect that this improved vascularity may have on healing outcomes is mixed. In an experimental goat model for chronic tibial osteomyelitis, Salgado et al. [50] found no significant difference in the incidence of recurrent disease at 1 year following debridement and coverage between muscle (n=13) or fasciocutaneous (n=13) tissue. Similarly, retrospective reviews of patients who underwent either muscle or fasciocutaneous flaps for coverage of traumatic lower extremity wounds showed little difference in the bacterial count, rates of osteomyelitis, and quality of wound healing between flap types [515253]. Our data suggest that no significant differences are present in the rates of wound healing or infection between these 2 flap types, which may shift the discussion of flap selection to focus on other, more patient-centered factors.

At issue is achieving a level of postoperative function acceptable to patients who had previously undergone joint replacement as a means to improving quality of life. The harvest of muscles of the posterior compartment of the calf is not without consequences in terms of postoperative loss of function that may not be seen with fasciocutaneous flap harvest. This is particularly important in ambulatory patients and/or high-performance athletes. The gastrocnemius and soleus muscles are important stabilizers of the ankle and knee and play a vital role in propelling the foot forward during the gait cycle. Previous reports have suggested that the use of these muscles in wound coverage can result in significant reductions in patient function. Knopp et al. [53] performed isokinetic testing on patients who had undergone local muscle flap transfer with a mean follow-up of 3 years. The authors reported a 21% reduction in foot flexion after gastrocnemius muscle harvest and a 20% reduction after soleus muscle harvest. Kramers-de Quervain et al. [54] reported 5 subjects who experienced significant decreases in ground-reaction forces and push-off forces in the operative leg after either gastrocnemius or soleus muscle flaps. They reported a calcaneal gait in up to 60% of the operative cohort. Furthermore, this objective functional deficit has been shown to correlate with patient-perceived disability. In a patient-centered, retrospective review by Daigeler et al. [55] of 218 patients who underwent local gastrocnemius muscle flaps for lower extremity wound coverage, 20% reported considerable difficulty using stairs, 28% were unable to stand on the operative leg alone, and 64% could not jump. Of the 42% of patients who could run postoperatively, 70% reported weakness when doing so. All patients who had undergone lateral gastrocnemius flaps experienced peroneal nerve palsy, with only 66% of patients fully recovering. Seventy-two percent of patients reported impaired sensibility in the operative leg. Not insignificantly, 13% of patients reported their function as insufficient or poor, and patients under 40 years old were more likely than older patients to rate their functional status as having worsened (P=0.03). Given these data, use of a gastrocnemius or soleus muscle flap may be a poor option in younger, more active patients whose functional demands often necessitate maintenance of sensibility, power, and plantar flexion.

The functional deficit that may result from muscle flap harvest contrasts with the results of fasciocutaneous flaps. Although technically more challenging, the harvest of fasciocutaneous tissue is associated with minimal functional morbidity. In a prospective study of postoperative function following 220 anterolateral thigh flaps, Hanasono et al. [56] reported no decrease in the range of motion of the donor leg and a 100% rate of return to the preoperative level of function. In an extremity that is already compromised, preservation of the leg musculature is imperative and may justify the more intricate dissection of fasciocutaneous flap harvest. Furthermore, a muscle-sparing approach may also allow easier flap re-elevation for staged revisions and implant exchanges, which are often required in the setting of infected prostheses. It is important to note that although our review included only pedicled flaps, microsurgical free tissue transfer may allow for more the frequent use of fasciocutaneous flaps, as various donor sites may be used for harvest and the recipient vessels surrounding the knee are large in caliber, facilitating microsurgical anastomoses.

In our review, we noted that clear and consistent reporting of functional and/or objective outcomes following soft tissue coverage of TKA wounds was lacking, with few studies reporting on practical outcomes such as ambulation, range of motion, and/or quality of life. Even fewer studies made use of validated outcome scales to measure these variables (KSS, WOMAC, SF-12, etc.). Only 3 studies in which functional outcomes were reported were identified in this review. Corten et al. [27] provided results from 3 validated scales (KSS, WOMAC, and SF-12) to show significant improvement in function after successful coverage of a compromised prosthetic joint with gastrocnemius muscle flaps. McPherson et al. [34] also reported improvements in KSS scores after gastrocnemius muscle flap coverage. Similarly, Vaienti et al. [41] reported good or excellent KSS scores in their series of 15 patients undergoing sural artery perforator flap coverage. Importantly, no study offered a direct comparison between muscle and fasciocutaneous flaps using validated outcome measures. Given that patients who undergo TKA are likely intent on returning to an active lifestyle, a validated assessment of postoperative function is paramount to achieving this end.

This study is not without its limitations. The heterogeneity among the data sources and lack of reported functional outcomes limits the role of statistical analysis as well as the ability to make meaningful comparisons between specific flap types. These factors are illustrated by the significant statistical heterogeneity found during the meta-analysis of the primary outcomes. In addition, differences in defect characteristics including size, depth, and exposed hardware existed among the reviewed papers. It can be presumed that fasciocutaneous flaps may have been selected in smaller or less complex defects, which may explain the favorable results seen in this group. It is important to note that the majority of patients in the fasciocutaneous flap cohort had undergone TKA following oncologic resection of the knee joint, while those in the muscle flap cohort underwent TKA for an unknown etiology or osteoarthritis. These differences, however, were not statistically significant. Selection bias within the published literature may have also influenced the results, as reflected in the high degree of heterogeneity among the published reports. For example, flap coverage differed between patients undergoing single- or 2-stage revision. Although the vast majority of pedicled fasciocutaneous flaps were performed following single-stage replacements, this trend did not hold true for the muscle flap cohort, which exhibited with a more split divide between single- and 2-stage reconstructions. These differences are likely explained by the presumed degree of infection and soft tissue breakdown in the patients who required more aggressive management, which may have contributed to selection bias. Furthermore, as in any systematic review, publication bias may be a factor in skewing the results, particularly in the surgical literature, which selects for the publication of results favoring an intervention. Lastly, the time to follow-up for functional outcomes varied widely, with longer follow-up noted in the muscle-only group (the mean follow-up duration for patients in the muscle and fasciocutaneous cohorts was 6.4 years and 1.6 years, respectively), which may have affected our analysis.

With the increasing number of joint replacements performed each year, a comprehensive investigation into the optimal management of compromised TKA is increasingly important. A critical look at the outcomes of various methods used to treat soft tissue defects following TKA will be necessary to identify the most effective and pragmatic approach to reconstruction, while optimizing functional prognosis, limb salvage, morbidity, and quality of life postoperatively. The results presented here demonstrate that the technical outcomes following reconstruction with either muscle or fasciocutaneous flaps are equivalent. Given the potential for functional morbidity from the use of muscle flaps, and all else being equal, we posit that fasciocutaneous flaps should be considered in a younger or more active patient population. Further research providing a direct comparison of functional outcomes between flap types must be undertaken using validated outcome scales.

Pooled rates of limb salvage across all studies (Cochran Q=40, df=17, P<0.0001; I2=57.5). df, degrees of freedom; LCL, lower confidence limits; UCL, upper confidence limits; WGHT, weight.

Notes

No potential conflict of interest relevant to this article was reported.

References

1. Galat DD, McGovern SC, Larson DR, et al. Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg Am 2009;91:48–54. 19122078.
2. Peersman G, Laskin R, Davis J, et al. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001;(392):15–23.
3. Nahabedian MY, Mont MA, Orlando JC, et al. Operative management and outcome of complex wounds following total knee arthroplasty. Plast Reconstr Surg 1999;104:1688–1697. 10541170.
4. Jones RE. Wound healing in total joint arthroplasty. Orthopedics 2010;33:660. 20839686.
5. Johnson DP. The effect of continuous passive motion on wound-healing and joint mobility after knee arthroplasty. J Bone Joint Surg Am 1990;72:421–426. 2179218.
6. Patella V, Speciale D, Patella S, et al. Wound necrosis after total knee arthroplasty. Orthopedics 2008;31:807. 19292412.
7. Lian G, Cracchiolo A 3rd, Lesavoy M. Treatment of major wound necrosis following total knee arthroplasty. J Arthroplasty 1989;4:S23–S32. 2584984.
8. Vince K, Chivas D, Droll KP. Wound complications after total knee arthroplasty. J Arthroplasty 2007;22:39–44.
9. Dennis DA. Wound complications in total knee arthroplasty. Instr Course Lect 1997;46:165–169. 9143958.
10. Panni AS, Vasso M, Cerciello S, et al. Wound complications in total knee arthroplasty. Which flap is to be used? With or without retention of prosthesis? Knee Surg Sports Traumatol Arthrosc 2011;19:1060–1068. 21161178.
11. Nahabedian MY, Orlando JC, Delanois RE, et al. Salvage procedures for complex soft tissue defects of the knee. Clin Orthop Relat Res 1998;(356):119–124. 9917675.
12. Adam RF, Watson SB, Jarratt JW, et al. Outcome after flap cover for exposed total knee arthroplasties: a report of 25 cases. J Bone Joint Surg Br 1994;76:750–753. 8083264.
13. Andres LA, Casey WJ, Clarke HD. Techniques in soft tissue coverage around the knee. Tech Knee Surg 2009;8:119–125.
14. Tiengo C, Macchi V, Vigato E, et al. Reversed gracilis pedicle flap for coverage of a total knee prosthesis. J Bone Joint Surg Am 2010;92:1640–1646. 20595571.
15. Jung JA, Kim YW, Cheon YW. Reverse gracilis muscle flap: an alternative means of skin coverage for recurrent infection after TKA. Knee Surg Sports Traumatol Arthrosc 2013;21:2779–2783. 23001017.
16. Demirseren ME, Efendioglu K, Demiralp CO, et al. Clinical experience with a reverse-flow anterolateral thigh perforator flap for the reconstruction of soft-tissue defects of the knee and proximal lower leg. J Plast Reconstr Aesthet Surg 2011;64:1613–1620. 21784720.
17. Moscatiello F, Masia J, Carrera A, et al. The ‘propeller’ distal anteromedial thigh perforator flap: anatomic study and clinical applications. J Plast Reconstr Aesthet Surg 2007;60:1323–1330. 17499568.
18. Kim JS, Lee HS, Jang PY, et al. Use of the descending branch of lateral circumflex femoral artery as a recipient pedicle for coverage of a knee defect with free flap: anatomical and clinical study. Microsurgery 2010;30:32–36. 19774629.
19. Busfield BT, Huffman GR, Nahai F, et al. Extended medial gastrocnemius rotational flap for treatment of chronic knee extensor mechanism deficiency in patients with and without total knee arthroplasty. Clin Orthop Relat Res 2004;(428):190–197.
20. Insall JN, Dorr LD, Scott RD, et al. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989;(248):13–14. 2805470.
21. Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003;73:712–716. 12956787.
22. Clopper CJ, Pearson ES. The Use of Confidence or Fiducial Limits Illustrated in the Case of the Binomial. Biometrika 1934;26:404–413.
23. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857–872. 9595616.
24. Agresti A, Coull BA. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 1998;52:119–126.
25. Akhtar MS, Khan AH, Khurram MF, et al. Inferiorly based thigh flap for reconstruction of defects around the knee joint. Indian J Plast Surg 2014;47:221–226. 25190918.
26. Chim H, Tan BK, Tan MH, et al. Optimizing the use of local muscle flaps for knee megaprosthesis coverage. Ann Plast Surg 2007;59:398–403. 17901731.
27. Corten K, Struelens B, Evans B, et al. Gastrocnemius flap reconstruction of soft-tissue defects following infected total knee replacement. Bone Joint J 2013;95-B:1217–1221. 23997135.
28. Gerwin M, Rothaus KO, Windsor RE, et al. Gastrocnemius muscle flap coverage of exposed or infected knee prostheses. Clin Orthop Relat Res 1993;(286):64–70.
29. Gravvanis AI, Iconomou TG, Panayotou PN, et al. Medial gastrocnemius muscle flap versus distally based anterolateral thigh flap: conservative or modern approach to the exposed knee joint? Plast Reconstr Surg 2005;116:932–934. 16141853.
30. Greenberg B, LaRossa D, Lotke PA, et al. Salvage of jeopardized total-knee prosthesis: the role of the gastrocnemius muscle flap. Plast Reconstr Surg 1989;83:85–89. 2909081.
31. Hallock GG. Chimeric gastrocnemius muscle and sural artery perforator local flap. Ann Plast Surg 2008;61:306–309. 18724133.
32. Han SE, Lee KT, Mun GH. Muscle-chimaeric medial sural artery perforator flap: a new design for complex three-dimensional knee defect. J Plast Reconstr Aesthet Surg 2014;67:571–574. 24100203.
33. Markovich GD, Dorr LD, Klein NE, et al. Muscle flaps in total knee arthroplasty. Clin Orthop Relat Res 1995;(321):122–130.
34. McPherson EJ, Patzakis MJ, Gross JE, et al. Infected total knee arthroplasty. Two-stage reimplantation with a gastrocnemius rotational flap. Clin Orthop Relat Res 1997;(341):73–81.
35. Misra A, Niranjan NS. Fasciocutaneous flaps based on fascial feeder and perforator vessels for defects in the patellar and peripatellar regions. Plast Reconstr Surg 2005;115:1625–1632. 15861067.
36. Papp A, Kettunen J, Miettinen H. Pedicled gastrocnemius flap in complicated total knee arthroplasty. Scand J Surg 2003;92:156–159. 12841557.
37. Pozzobon LR, Helito CP, Guimaraes TM, et al. Rotation flaps for coverage after total knee arthroplasty. Acta Ortop Bras 2013;21:219–222. 24453672.
38. Ries MD. Skin necrosis after total knee arthroplasty. J Arthroplasty 2002;17:74–77. 12068411.
39. Siim E, Jakobsen IE, Medgyesi S. Soft-tissue procedures for the exposed knee arthroplasty. 18 cases followed for 7 (1–17) years. Acta Orthop Scand 1991;62:312–314. 1882667.
40. Taniguchi Y, Kitano T, Shimoe T, et al. Superior lateral genicular artery flap for coverage of a soft tissue defect after total knee arthroplasty. J Reconstr Microsurg 2009;25:479–482. 19672819.
41. Vaienti L, Menozzi A, Lonigro J, et al. The salvage of knee-exposed prosthesis using neurofasciocutaneous sural flap. Musculoskelet Surg 2010;94:33–40. 20204562.
42. Alexiades M, Sands A, Craig SM, et al. Management of selected problems in revision knee arthroplasty. Orthop Clin North Am 1989;20:211–219. 2646564.
43. Lidwell OM, Lowbury EJ, Whyte W, et al. Infection and sepsis after operations for total hip or knee-joint replacement: influence of ultraclean air, prophylactic antibiotics and other factors. J Hyg (Lond) 1984;93:505–529. 6512253.
44. Vince KG, Abdeen A. Wound problems in total knee arthroplasty. Clin Orthop Relat Res 2006;452:88–90. 17079990.
45. Casanova D, Hulard O, Zalta R, et al. Management of wounds of exposed or infected knee prostheses. Scand J Plast Reconstr Surg Hand Surg 2001;35:71–77. 11291354.
46. Menderes A, Demirdover C, Yilmaz M, et al. Reconstruction of soft tissue defects following total knee arthroplasty. Knee 2002;9:215–219. 12126680.
47. Moller AM, Pedersen T, Villebro N, et al. Effect of smoking on early complications after elective orthopaedic surgery. J Bone Joint Surg Br 2003;85:178–181. 12678348.
48. Gosain A, Chang N, Mathes S, et al. A study of the relationship between blood flow and bacterial inoculation in musculocutaneous and fasciocutaneous flaps. Plast Reconstr Surg 1990;86:1152–1162. 2243859.
49. Harry LE, Sandison A, Pearse MF, et al. Comparison of the vascularity of fasciocutaneous tissue and muscle for coverage of open tibial fractures. Plast Reconstr Surg 2009;124:1211–1219. 19935305.
50. Salgado CJ, Mardini S, Jamali AA, et al. Muscle versus nonmuscle flaps in the reconstruction of chronic osteomyelitis defects. Plast Reconstr Surg 2006;118:1401–1411. 17051111.
51. Rodriguez ED, Bluebond-Langner R, Copeland C, et al. Functional outcomes of posttraumatic lower limb salvage: a pilot study of anterolateral thigh perforator flaps versus muscle flaps. J Trauma 2009;66:1311–1314. 19430232.
52. Yazar S, Lin CH, Lin YT, et al. Outcome comparison between free muscle and free fasciocutaneous flaps for reconstruction of distal third and ankle traumatic open tibial fractures. Plast Reconstr Surg 2006;117:2468–2475. 16772958.
53. Knopp W, Buchholz J, Muhr G, et al. Negative effects of local tibial muscle flap repair on foot function. Unfallchirurg 1993;96:229–234. 8327894.
54. Kramers-de Quervain IA, Lauffer JM, Kach K, et al. Functional donor-site morbidity during level and uphill gait after a gastrocnemius or soleus muscle-flap procedure. J Bone Joint Surg Am 2001;83:239–246. 11216686.
55. Daigeler A, Drucke D, Tatar K, et al. The pedicled gastrocnemius muscle flap: a review of 218 cases. Plast Reconstr Surg 2009;123:250–257. 19116559.
56. Hanasono MM, Skoracki RJ, Yu P. A prospective study of donor-site morbidity after anterolateral thigh fasciocutaneous and myocutaneous free flap harvest in 220 patients. Plast Reconstr Surg 2010;125:209–214. 19910852.

Article information Continued

Fig. 1

Forest plot of limb salvage

Pooled rates of limb salvage across all studies (Cochran Q=40, df=17, P<0.0001; I2=57.5). df, degrees of freedom; LCL, lower confidence limits; UCL, upper confidence limits; WGHT, weight.

Fig. 2

Forest plot of device salvage

Pooled rates of device salvage across all studies (Cochran Q=18, df=13, P=0.16; I2=62.5). df, degrees of freedom; LCL, lower confidence limits; UCL, upper confidence limits; WGHT, weight.

Fig. 3

Forest plot of ambulation rates

Pooled rates of postoperative ambulation across all studies (Cochran Q=4, df=11, P=0.46; I2=1.75). df, degrees of freedom; LCL, lower confidence limits; UCL, upper confidence limits; WGHT, weight.

Fig. 4

Funnel plot of limb salvage

Funnel plot representation of publication bias in the reporting of rates of limb salvage. SD, standard deviation.

Fig. 5

Funnel plot of device salvage

Funnel plot representation of publication bias in the reporting of rates of device salvage. SD, standard deviation.

Fig. 6

Funnel plot of ambulation rates

Funnel plot representation of publication bias in the reporting of rates of postoperative ambulation. SD, standard deviation.

Fig. 7

Study attrition diagram

Diagram showing the study selection process and attrition.

Table 1

Description of studies on flap coverage of total knee arthroplasty and assessment of study quality

Study Study size Study design Minors score Level of evidence
Akhtar et al., 2014 [25] 1 CR 12 IV
Chim et al., 2007 [26] 10 CS 12 IV
Corten et al., 2013 [27] 24 CS 16 IV
Demirseren et al., 2011 [16] 17 CS 16 IV
Gerwin et al., 1992 [28] 12 CS 14 IV
Gravvanis et al., 2006 [29] 2 CS 12 IV
Greenberg et al., 1988 [30] 10 CS 13 IV
Hallock, 2008 [31] 2 CS 12 IV
Han et al., 2014 [32] 2 CS 12 IV
Markovich et al., 1995 [33] 4 CS 12 IV
McPherson et al., 1997 [34] 21 CS 15 IV
Misra and Niranjan, 2005 [35] 5 CS 13 IV
Papp et al., 2003 [36] 10 CS 15 IV
Pozzobon et al., 2013 [37] 9 CS 15 IV
Ries, 2006 [38] 12 CS 15 IV
Siim et al., 1991 [39] 10 CS 13 IV
Taniguchi et al., 2009 [40] 1 CR 12 IV
Vaienti et al., 2010 [41] 15 CS 13 IV

CR, case report; CS, case series.

Table 2

Outcomes of the studies included in the review

Study Study size Diagnosis Flap types Limb salvage rate (%) Device salvage rate (%) Ambulation rate (%) Complication rate (%) Functional outcomes reported
Akhtar et al., 2014 [25] 1 OA 1 Anterolateral thigh 1 100 100 100 0
Chim et al., 2007 [26] 10 OR 10 Gastrocnemius 10 100 100 100 30
Hemisoleus 2
Gracilis 1
Semimembranosus 1
Corten et al., 2013 [27] 24 OA 20 Gastrocnemius 24 100 91.6 - - KSS, WOMAC, SF-12
RA 3 100
Demirseren et al., 2011 [16] 17 OR 1 Anterolateral thigh 17 100 70.6 100 11.8
OA 12
Gerwin et al., 1992 [28] 12 Gastrocnemius 12 91.7 83.3 - -
Gravvanis et al., 2006 [29] 2 Gastrocnemius 2 100 50 0
Greenberg et al., 1988 [30] 10 OA 3 Gastrocnemius 10 100 80 - -
RA 6
Hallock, 2008 [31] 2 OA 1 Anterolateral thigh 1 100 100 100 2
1 Gastrocnemius 1
Han et al., 2014 [32] 2 OA 2 Sural artery perforator 2 100 100 100 0
Markovich et al., 1995 [33] 4 OA 1 Gastrocnemius 4 100 100 1
RA 1
McPherson et al., 1997 [34] 21 Gastrocnemius 21 100 - 61.9 KSS
Misra and Niranjan, 2005 [35] 5 OA 5 Local fasciocutaneous 5 100 100 100 0
Papp et al., 2003 [36] 10 OA 6 Gastrocnemius 10 90 80 70 50
RA 4
Pozzobon et al., 2013 [37] 9 OA 2 Gastrocnemius 9 55.6 44 56 1
RA 5
Ries, 2006 [38] 12 OA 1 Gastrocnemius 12 100 - 50
RA 1
Siim et al., 1991 [39] 10 OA 1 Local fasciocutaneous flap 10 100 40 33 33.3
Taniguchi et al., 2009 [40] 1 OR 1 Gastrocnemius 1 100 100 100 0
Vaienti et al., 2010 [41] 15 Sural artery perforator 15 100 100 - 20 KSS

OA, osteoarthritis; OR, oncologic resection; RA, rheumatoid arthritis; KSS, knee society scale; WOMAC, Western Ontario and McMaster Universities osteoarthritis index; SF-12, short form 12.

Table 3

Comparison of population characteristics between patient cohorts undergoing flap coverage of total knee arthroplasty defects

Characteristic Muscle cohort (n=119) Fasciocutaneous cohort (n=53) P-value
Demographic characteristics
 Age (yr, mean [range]) 55 (31–70.1) 49.9 (36–69.5) 0.97
 Sex (% male) 54.5 76 0.29
Primary diagnosis (%)
 Osteoarthritis 32.7 53.8 0.24
 Oncologic resection 10 41.2 0.18
 Rheumatoid arthritis 16.8 - -
Indications for flap
 reconstruction (%)
 Infection 84.1 78.8 0.05
 Wound healing complications 15.9 21.2 0.23
Characteristics of prosthesis management
 Stages (%) 0.06
  Single stage 55.3 87
  Two stage 44.7 13

Table 4

Outcomes following muscle or fasciocutaneous flap coverage of compromised total knee arthroplasty

Outcome Muscle Cohort (n = 119) Fasciocutaneous Cohort (n = 53) P-value
Mean 95% Confidence interval 95% Confidence 95% Confidence interval
Follow-up (yr) 6.4 (0.25–20.5) 1.6 (0.25–4.8) 0.19
Complications (%)
 Overall 47.3 47.02–47.58 44 43.41–44.49 0.78
 Flap loss, total 9.1 8.49–9.71 16 15.33–16.67 0.39
 Flap loss, partial 1.8 1.37–2.23 1.6 0.83–2.37 0.45
 Wound breakdown 12.7 12.45–12.95 8 7.49–8.51 0.2
 Persistent infection 16.7 10.55–22.85 0 - 0.14
 New infection 9.1 8.85–9.35 4 3.74–4.26 0.94
 Reoperation 32.7 31.09–35.31 44 42.89–45.11 0.86
 Flap revision 7.3 5.3–9.3 12 10.89–13.11 0.53
 Arthrodesis 7.3 7.05–7.55 9.3 9.12–9.48 0.12
Salvage rates
 Limb salvage (%) 89.8 88.43–91.17 100 - 0.14
 Prosthesis salvage (%) 82.5 82.38–82.62 88.8 88.64–88.96 0.05
Functional outcomes
 Ambulation (%) 75.2 51.4–99 91.6 84.3–98.9 0.25
 Time to ambulation (wk) 2 13.8 0.57

Table 5

Studies reporting functional outcomes using validated scales following flap coverage of compromised total knee arthroplasty

Study Flap types Preoperative Postoperative
Corten et al., 2013 [27] Muscle
 KSS 53 103
 WOMAC 43 51
 SF-12
  Mental component 47.69 49.76
  Physical component 28.24 32.17
McPherson et al., 1997 [34] Muscle
 KSS 10.5 77
 Prosthesis salvage (%) 88.8 90.1
Vaienti et al., 2010 [41] Fasciocutaneous
 KSS “good” or “excellent”

KSS, knee society scale; WOMAC, Western Ontario and McMaster Universities osteoarthritis index; SF-12, short form 12.